| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/29/2004 | US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 04/29/2004 | US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082547 Prevent thrombosis; anticholesterol agents; cardiovascular disorders; anticancer agents |
| 04/29/2004 | US20040082518 Antiinflammatory/coagulant prodrug |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent |
| 04/29/2004 | US20040081624 Mixture containing high volatility carrier; vaporization; mixing with air |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2502510A1 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| 04/29/2004 | CA2502221A1 Plasma preparation or serum preparation and process for producing the same |
| 04/29/2004 | CA2501999A1 Compositions and methods for inducing osteogenesis |
| 04/28/2004 | EP1413580A1 Furanone derivatives as inhibitors of Cathepsin S |
| 04/28/2004 | EP1413305A1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
| 04/28/2004 | EP1413174A1 Mounting arrangement for auxiliary burner or lance |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412388A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 04/28/2004 | EP1412378A1 Aptamers and antiaptamers |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 04/28/2004 | EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412320A1 Linked cyclitols and their polysulfated derivatives |
| 04/28/2004 | EP1411994A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 04/28/2004 | EP1411973A1 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
| 04/28/2004 | EP1411953A1 Methods and compositions for treatment of gastric diseases |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411918A2 Methods to mobilize progenitor/stem cells |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411890A1 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP1128841B1 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 04/28/2004 | EP0888271B1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| 04/28/2004 | EP0655925B1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 04/28/2004 | EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 04/28/2004 | CN1492873A Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1492759A Device and method for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 04/28/2004 | CN1492737A Functional agent for decomposing nicotine and method of preparing the same |
| 04/28/2004 | CN1491942A Non humidity suction stable crystalline form of N-[N-N-(4-piperidine-4-yl)-N-ethyl glycyl) compound |
| 04/28/2004 | CN1491690A Process for preparing Chinese medicine soft capsule for treating and preventing thrombotic obliterating disease |
| 04/28/2004 | CN1491682A Recovery capsule for infarct |
| 04/28/2004 | CN1491661A Total penoniforn preparation and its use |
| 04/28/2004 | CN1491658A Notiginseng total saponin liposome and its preparation |
| 04/28/2004 | CN1491654A Process for preparing selenium aspirin enteric tablet and its use of resisting thrombosis |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
| 04/28/2004 | CN1147322C Iron-dextran compound and its preparing process and use |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/27/2004 | US6727363 From toluene/diethyl ether mixture; recovering, drying |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727261 Pyrido[2,1-A]Isoquinoline derivatives |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | US6726653 Indwelling heat exchange catheter and method of using same |
| 04/27/2004 | CA2118929C (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 04/22/2004 | WO2004033681A1 Substance having activity of promoting platelet aggregation |
| 04/22/2004 | WO2004033620A2 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | WO2004033503A1 Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same |
| 04/22/2004 | WO2004033042A1 Treatment of amm |
| 04/22/2004 | WO2004032952A1 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 04/22/2004 | WO2004032917A1 Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction |
| 04/22/2004 | WO2004019758A3 Methods of treating idiopathic pulmonary fibrosis |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003057722A3 Cyclic tetrapeptide compound and use thereof |
| 04/22/2004 | WO2003040176A3 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002098362A3 Use of rank antagonists to treat cancer |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077868 Process |
| 04/22/2004 | US20040077855 Thrombopoietin mimetics |
| 04/22/2004 | US20040077831 Methods for removing analytes such as proteins, from biological compositions such as blood; blood cells prepared in this manner remain viable following prolonged storage and are suitable for therapeutic use e.g. in transfusion applications |
| 04/22/2004 | US20040077697 2-Acylaminothiazole derivative or its salt |
| 04/22/2004 | US20040077690 Anticoagulants; cardiovascular and brain disorders |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077663 Thienopyrimidine-based inhibitors of the src family |
| 04/22/2004 | US20040077658 Respiratory system, nervous system, brain, gastrointestinal and psychological disorders; chronic obstructive pulmonary disease; antiasthmatics, analgesics |
| 04/22/2004 | US20040077639 Administering amidine derivative as antiasthmatic agents; chronic obstructive pulmonary disease treatment |